Authors' response to "Evaluation of Treatments for HIV-Associated Kaposi Sarcoma in Africa"

Infect Agent Cancer. 2021 May 5;16(1):27. doi: 10.1186/s13027-021-00372-5.

Authors

Matthew E Coldiron¹, Ana Gabriela Gutierrez Zamudio², Rolanda Manuel³, Iza Ciglenecki⁴, Laurence Toutous Trellu⁵, Lucas Molfino²

Affiliations

¹ Epicentre, 14-34 Avenue Jean Jaurès, 75019, Paris, France. matthew.coldiron@epicentre.msf.org.
² Médecins Sans Frontières, Maputo, Mozambique.
³ Ministry of Health, Maputo, Mozambique.
⁴ Médecins Sans Frontières, Geneva, Switzerland.
⁵ University Hospitals of Geneva, Geneva, Switzerland.

No abstract available

Keywords: AIDS-related opportunistic infections; Acquired Immunodeficiency Syndrome; Doxorubicin; Kaposi sarcoma; Mozambique.

Publication types

Letter

Grants and funding

NA/Médecins Sans Frontières